CYPH
What one share of Cypherpunk Technologies holds
Pharmaceutical Preparations
We were incorporated in the state of Delaware on January 3, 2011. Our wholly owned subsidiaries as of December 31, 2025 include HealthCare Pharmaceuticals Pty Ltd. (“HCP Australia”), Leap Securities Corp., Flame Biosciences LLC, and Leap Therapeutics, Inc.
Cypherpunk Technologies’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$0.01 |
|---|---|
| Cash and investments | $0.07 |
| Book value | $1.29 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2017 | — | −$33.13 | $0.07 | −$24.16 | — | $9.00 |
| 2018 | — | −$21.11 | — | −$18.06 | — | $6.24 |
| 2019 | — | −$14.73 | $0.04 | −$11.96 | — | −$0.72 |
| 2020 | $0.25 | −$6.34 | — | −$4.38 | — | $7.82 |
| 2021 | $0.17 | −$4.73 | — | −$4.10 | — | $18.08 |
| 2022 | — | −$4.82 | — | −$4.33 | — | $5.94 |
| 2023 | — | −$3.98 | — | −$2.14 | — | $2.35 |
| 2024 | — | −$1.81 | — | −$1.61 | — | $0.91 |
| 2025 | — | $0.07 | — | −$0.62 | — | $1.83 |